These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Peptide triazole inactivators of HIV-1: how do they work and what is their potential? Chaiken I; Rashad AA Future Med Chem; 2015; 7(17):2305-10. PubMed ID: 26599515 [No Abstract] [Full Text] [Related]
8. Recognition of HIV-inactivating peptide triazoles by the recombinant soluble Env trimer, BG505 SOSIP.664. Acharya K; Rashad AA; Moraca F; Klasse PJ; Moore JP; Abrams C; Chaiken I Proteins; 2017 May; 85(5):843-851. PubMed ID: 28056499 [TBL] [Abstract][Full Text] [Related]
9. Introducing metallocene into a triazole peptide conjugate reduces its off-rate and enhances its affinity and antiviral potency for HIV-1 gp120. Gopi H; Cocklin S; Pirrone V; McFadden K; Tuzer F; Zentner I; Ajith S; Baxter S; Jawanda N; Krebs FC; Chaiken IM J Mol Recognit; 2009; 22(2):169-74. PubMed ID: 18498083 [TBL] [Abstract][Full Text] [Related]
11. The active core in a triazole peptide dual-site antagonist of HIV-1 gp120. Umashankara M; McFadden K; Zentner I; Schön A; Rajagopal S; Tuzer F; Kuriakose SA; Contarino M; Lalonde J; Freire E; Chaiken I ChemMedChem; 2010 Nov; 5(11):1871-9. PubMed ID: 20677318 [TBL] [Abstract][Full Text] [Related]
12. A model of peptide triazole entry inhibitor binding to HIV-1 gp120 and the mechanism of bridging sheet disruption. Emileh A; Tuzer F; Yeh H; Umashankara M; Moreira DR; Lalonde JM; Bewley CA; Abrams CF; Chaiken IM Biochemistry; 2013 Apr; 52(13):2245-61. PubMed ID: 23470147 [TBL] [Abstract][Full Text] [Related]
13. Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus-Cell Interface. Rashad AA; Song LR; Holmes AP; Acharya K; Zhang S; Wang ZL; Gary E; Xie X; Pirrone V; Kutzler MA; Long YQ; Chaiken I J Med Chem; 2018 Jun; 61(11):5020-5033. PubMed ID: 29767965 [TBL] [Abstract][Full Text] [Related]
15. Peptide Triazole Inactivators of HIV-1 Utilize a Conserved Two-Cavity Binding Site at the Junction of the Inner and Outer Domains of Env gp120. Aneja R; Rashad AA; Li H; Kalyana Sundaram RV; Duffy C; Bailey LD; Chaiken I J Med Chem; 2015 May; 58(9):3843-58. PubMed ID: 25860784 [TBL] [Abstract][Full Text] [Related]
17. Entry inhibitors directed towards glycoprotein gp120: an overview on a promising target for HIV-1 therapy. Flores A; Quesada E Curr Med Chem; 2013 Feb; 20(6):751-71. PubMed ID: 23278399 [TBL] [Abstract][Full Text] [Related]